Cyanotech stock: Fiscal Q2 sales rise to 6.976 million USD
Published on 11/05/2026 at 01:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSSales growth meets continued pressure
- Cyanotech's fiscal second-quarter revenue reached 6.976 million USD, up from 5.845 million USD a year earlier.
- Quarterly earnings per share were 0.00 USD on a non-GAAP basis, according to Benzinga's earnings page.
Cyanotech's fiscal second-quarter sales increased to 6.976 million USD from 5.845 million USD a year earlier, according to Benzinga. The figures point to stronger year-over-year demand in the period, although the company remained under pressure at the earnings level.
Revenue improves while earnings remain weak
Benzinga's earnings table lists fiscal Q2 earnings per share at 0.00 USD on a non-GAAP basis. The prior fiscal quarter showed a loss of 0.13 USD per share, while quarterly revenue was listed at 5.8 million USD.
The sales increase offers a more supportive operating signal than the recent quarterly loss history. Investors will nevertheless continue to focus on whether higher revenue can translate into sustained profitability and stronger liquidity.
Microalgae products anchor the business
Cyanotech develops nutrition and health products based on microalgae, including spirulina and astaxanthin products. Its portfolio serves the dietary supplement and wellness markets, making revenue growth dependent on consumer demand for specialty nutritional ingredients.
Broader US equity-market developments provide the wider backdrop for small-cap investors; see Current market reports.
